Dr John Wesley Mcconnell, MD - Medicare Pulmonary Disease in Louisville, KY

Dr John Wesley Mcconnell, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Louisville, Kentucky. He went to Medical College Of Georgia School Of Medicine and graduated in 1982 and has 42 years of diverse experience with area of expertise as Pulmonary Disease. He is a member of the group practice Community Medical Associates Inc and his current practice location is 100 W Market St Ste 2, Louisville, Kentucky. You can reach out to his office (for appointments etc.) via phone at (502) 587-8000.

Dr John Wesley Mcconnell is licensed to practice in Kentucky (license number 22726) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1902831761.

Contact Information

Dr John Wesley Mcconnell, MD
100 W Market St Ste 2,
Louisville, KY 40202-1332
(502) 587-8000
(502) 583-8001



Physician's Profile

Full NameDr John Wesley Mcconnell
GenderMale
SpecialityPulmonary Disease
Experience42 Years
Location100 W Market St Ste 2, Louisville, Kentucky
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr John Wesley Mcconnell attended and graduated from Medical College Of Georgia School Of Medicine in 1982
  NPI Data:
  • NPI Number: 1902831761
  • Provider Enumeration Date: 07/11/2006
  • Last Update Date: 01/26/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 8527956010
  • Enrollment ID: I20100116000049

Medical Identifiers

Medical identifiers for Dr John Wesley Mcconnell such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1902831761NPI-NPPES
64227267MedicaidKY

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RP1001XInternal Medicine - Pulmonary Disease 22726 (Kentucky)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Norton Hospitals, IncLouisville, KYHospital
Clark Memorial HospitalJeffersonville, INHospital
Hardin Memorial HospitalElizabethtown, KYHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Community Medical Associates Inc70128112841098

News Archive

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.

Anti-TNFs increase risk of shingles in patients with inflammatory rheumatic diseases

Patients with inflammatory rheumatic diseases (IRD) treated with anti-tumour necrosis factor medications (anti-TNFs) have a 75% greater risk of developing herpes zoster, or shingles, than patients treated with traditional disease modifying anti-rheumatic drugs (DMARDs), according to a meta-analysis presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism.

OxThera announces initiation of Oxabact clinical study in Primary Hyperoxaluria

OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.

Oxygen therapy may prevent diabetics losing limbs

Researchers say on a daily basis around 275 Australians develop type 2 diabetes and worldwide, every 30 seconds a person somewhere has a lower limb amputated because of diabetic foot disease.

Researchers seek to understand the causes of 'cybersickness' and ways to prevent it

‘Cybersickness' might sound right out of a sci-fi novel, but it's an illness impacting people across industries today. UNSW Sydney researchers are trying to understand what causes this sickness – and how to prevent it.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr John Wesley Mcconnell allows following entities to bill medicare on his behalf.
Entity NameUniversity Of Kentucky
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1770771974
PECOS PAC ID: 3072425289
Enrollment ID: O20031105000072

News Archive

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.

Anti-TNFs increase risk of shingles in patients with inflammatory rheumatic diseases

Patients with inflammatory rheumatic diseases (IRD) treated with anti-tumour necrosis factor medications (anti-TNFs) have a 75% greater risk of developing herpes zoster, or shingles, than patients treated with traditional disease modifying anti-rheumatic drugs (DMARDs), according to a meta-analysis presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism.

OxThera announces initiation of Oxabact clinical study in Primary Hyperoxaluria

OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.

Oxygen therapy may prevent diabetics losing limbs

Researchers say on a daily basis around 275 Australians develop type 2 diabetes and worldwide, every 30 seconds a person somewhere has a lower limb amputated because of diabetic foot disease.

Researchers seek to understand the causes of 'cybersickness' and ways to prevent it

‘Cybersickness' might sound right out of a sci-fi novel, but it's an illness impacting people across industries today. UNSW Sydney researchers are trying to understand what causes this sickness – and how to prevent it.

Read more Medical News

› Verified 4 days ago

Entity NameCommunity Medical Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1588614994
PECOS PAC ID: 7012811284
Enrollment ID: O20031120000656

News Archive

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.

Anti-TNFs increase risk of shingles in patients with inflammatory rheumatic diseases

Patients with inflammatory rheumatic diseases (IRD) treated with anti-tumour necrosis factor medications (anti-TNFs) have a 75% greater risk of developing herpes zoster, or shingles, than patients treated with traditional disease modifying anti-rheumatic drugs (DMARDs), according to a meta-analysis presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism.

OxThera announces initiation of Oxabact clinical study in Primary Hyperoxaluria

OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.

Oxygen therapy may prevent diabetics losing limbs

Researchers say on a daily basis around 275 Australians develop type 2 diabetes and worldwide, every 30 seconds a person somewhere has a lower limb amputated because of diabetic foot disease.

Researchers seek to understand the causes of 'cybersickness' and ways to prevent it

‘Cybersickness' might sound right out of a sci-fi novel, but it's an illness impacting people across industries today. UNSW Sydney researchers are trying to understand what causes this sickness – and how to prevent it.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John Wesley Mcconnell is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr John Wesley Mcconnell, MD
Po Box 776351,
Chicago, IL 60677-6351

Ph: (502) 588-9490
Dr John Wesley Mcconnell, MD
100 W Market St Ste 2,
Louisville, KY 40202-1332

Ph: (502) 587-8000

News Archive

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.

Anti-TNFs increase risk of shingles in patients with inflammatory rheumatic diseases

Patients with inflammatory rheumatic diseases (IRD) treated with anti-tumour necrosis factor medications (anti-TNFs) have a 75% greater risk of developing herpes zoster, or shingles, than patients treated with traditional disease modifying anti-rheumatic drugs (DMARDs), according to a meta-analysis presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism.

OxThera announces initiation of Oxabact clinical study in Primary Hyperoxaluria

OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.

Oxygen therapy may prevent diabetics losing limbs

Researchers say on a daily basis around 275 Australians develop type 2 diabetes and worldwide, every 30 seconds a person somewhere has a lower limb amputated because of diabetic foot disease.

Researchers seek to understand the causes of 'cybersickness' and ways to prevent it

‘Cybersickness' might sound right out of a sci-fi novel, but it's an illness impacting people across industries today. UNSW Sydney researchers are trying to understand what causes this sickness – and how to prevent it.

Read more News

› Verified 4 days ago


Internal Medicine Doctors in Louisville, KY

Cindy J Code, M.D.
Pulmonary Disease
Medicare: Not Enrolled in Medicare
Practice Location: 3950 Kresge Way, Suite 303, Louisville, KY 40207
Phone: 502-896-1880    Fax: 502-896-1887
Dr. Uchenna Loretta Ozor, M.D
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 200 E Chestnut St Bldg Suite303, Louisville, KY 40202
Phone: 502-629-5552    Fax: 502-629-3132
Mohamed Hegazi, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 529 S Jackson St, Louisville, KY 40202
Phone: 502-562-4270    
Dr. Michael Patrick Krease, D.O.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1169 Eastern Pkwy Ste G58, Louisville, KY 40217
Phone: 502-452-9567    
Dr. Ramsey Nasri Nassar, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 6400 Dutchmans Pkwy, Ste 250, Louisville, KY 40205
Phone: 502-587-9660    Fax: 502-540-5615
Jeanne M Thompson, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 3 Audubon Plaza Dr, Ll2, Louisville, KY 40217
Phone: 502-636-8095    Fax: 502-636-8097
Terrence P Donohue, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 3101 Poplar Level Rd Ste 101, Louisville, KY 40213
Phone: 502-636-7444    Fax: 502-636-7112

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.